Target
Integrase
Ligand
BDBM503
Substrate
n/a
Meas. Tech.
ChEMBL_90733 (CHEMBL701285)
IC50
>100000±n/a nM
Citation
 Mazumder, AWang, SNeamati, NNicklaus, MSunder, SChen, JMilne, GWRice, WGBurke, TRPommier, Y Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. J Med Chem 39:2472-81 (1996) [PubMed]  Article 
Target
Name:
Integrase
Synonyms:
Human immunodeficiency virus type 1 integrase
Type:
PROTEIN
Mol. Mass.:
32231.48
Organism:
Human immunodeficiency virus 1
Description:
ChEMBL_90865
Residue:
288
Sequence:
FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKVKIIRDYGKQMAGDDCVASRQDED
  
Inhibitor
Name:
BDBM503
Synonyms:
3-benzyl-4,5-dihydroxy-2H-chromen-2-one | CHEMBL64588 | Cancer Chemotherapy National Service Center (CCNSC) compound 251156 | NSC 251156
Type:
Small organic molecule
Emp. Form.:
C16H12O4
Mol. Mass.:
268.2641
SMILES:
Oc1cccc2oc(=O)c(Cc3ccccc3)c(O)c12
Structure:
Search PDB for entries with ligand similarity: